We’ve blogged previously about the dangers of the weight loss drug Alli. Now, the Food and Drug Administration has issued a warning concerning Alli and its risk of severe liver injury. The popular weight loss drug has been taken by an estimated 40 million consumers. Xenical, which is available in prescription form, has also received an FDA warning concerning liver injury. Both Xenical and Alli contain 60 mg of orlistat. The FDA first approved Xenical in 1999, and Alli was approved in 2007.
Last year, the FDA began reviewing orlistat over safety concerns. At the time, the FDA had received 32 reports concerning serious liver injury.
Patients taking Alli or Xenical who’ve experienced symptoms of serious liver injury should call their healthcare professional. Symptoms of liver injury include itching, yellow eyes or skin, dark urine, loss of appetite, or light-colored stools.
Latest posts by Eva Bleich (see all)
- Federal Judge Finds Health Insurer DiscriminatedAgainst Patients with Substance Abuse and Mental Health Disorders - March 25, 2019
- Factors Impacting Maternal Health During Hospital Births - March 22, 2019
- Jury Awards $117 million in Johnson & Johnson’sFirst Trial Loss in Asbestos-Related, Talc Powder Lawsuits - April 24, 2018